4//SEC Filing
Eaton Bruce 4
Accession 0001415889-23-012049
CIK 0001650664other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:30 PM ET
Size
4.9 KB
Accession
0001415889-23-012049
Insider Transaction Report
Form 4
Eaton Bruce
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2023-08-08$8.39/sh−141$1,183→ 76,533 total
Footnotes (1)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2023. The sale does not represent a discretionary trade by the Reporting Person.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001874831
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:30 PM ET
- Size
- 4.9 KB